Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia +10 more·2016·Cell

DOI 10.1016/j.cell.2016.02.065

Cited by (1,009)

Items 801–900 of 1,009

Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma
Igor J. Puzanov, Antoni Ribas, Caroline Robert, Jacob Schachter, Marta Nyakas, ADIL I. DAUD, Ana Maria Arance, Matteo Salvatore Carlino, Steven J O'Day, Georgina Venetia Long et al. · 2020 · JAMA Oncology
A Gene Mutation Signature Predicting Immunotherapy Benefits in Patients With NSCLC
Dong Pan, Angela Y. Hu, Scott Joseph Antonia, Chuan‐Yuan Li · 2020 · Journal of Thoracic Oncology
Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review
Szonja Kovacs, Balázs Győrffy · 2022 · Journal of Translational Medicine
AXL Inhibitors: Status of Clinical Development
Sheena Bhalla, David E. Gerber · 2023 · Current Oncology Reports
Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma
Kui Cao, Jinhong Zhu, Mengdi Lu, Jinfeng Zhang, Yingnan Yang, Xiaodong Ling, Luquan Zhang, Cuicui Qi, Shenshui Wei, Yanqiao Zhang et al. · 2023 · EBioMedicine
IGSF8 is an innate immune checkpoint and cancer immunotherapy target
Yulong Li, Xiangyang Wu, Caibin Sheng, Hailing Liu, Huizhu Liu, Yixuan Tang, Chao Liu, Qingyang Ding, Bin Xie, Xi Xiao et al. · 2024 · Cell
Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies
Valencia Mc Neil, Seung Won Lee · 2025 · Cancers
Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation
Tomonori Yaguchi, Yutaka Kawakami · 2016 · International Immunology
Recent advances in understanding antitumor immunity
Rodrigo Ramella Munhoz, Michael Andrew Postow · 2016 · F1000Research
Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
Nicholas C. Borcherding, Ryan H. Kolb, Jodi A. Gullicksrud, Praveen Vikas, Yuwen Zhu, Weizhou Zhang · 2018 · Journal of Molecular Biology
Clinical responses to ERK inhibition in BRAF V600E-mutant colorectal cancer predicted using a computational model
Kirouac, Daniel C., Schaefer, Gabriele, Chan, Jocelyn, Merchant, Mark, Orr, Christine, Huang, Shih-Min A., Moffat, John, Liu, Lichuan, Gadkar, Kapil, Ramanujan, Saroja · 2017 · npj Systems Biology and Applications
Biomarkers for Immune Checkpoint Inhibitors in Melanoma
Shigehisa Kitano, Takayuki Nakayama, Makiko Yamashita · 2018 · Frontiers in Oncology
ScanNeo: identifying indel-derived neoantigens using RNA-Seq data
Ting-You Wang, Li Wang, Sk. Kayum Alam, Luke H. Hoeppner, Rendong Yang · 2019 · Bioinformatics
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Robert Ballotti, Yann Chéli, Corine Bertolotto · 2020 · Molecular Cancer
Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities
Davood Bashash, Zahra Zandi, Bahareh Kashani, Atieh Pourbagheri‐Sigaroodi, Sina Salari, Seyed Hamidollah Ghaffari · 2021 · Journal of Cellular Physiology
Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer
Grainne Mary O'Kane, Ashton Anthony Connor, Steve Gallinger · 2017 · Trends in Molecular Medicine
Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
Hongkai Zhuang, Zixuan Zhou, Zuyi Ma, Zhenchong Li, Chunsheng Liu, Shanzhou� Huang, Chuanzhao Zhang, Baohua Hou · 2020 · Journal of Cellular and Molecular Medicine
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab
Wungki Park, Deukwoo Kwon, Diana Saravia, Amrita J. Desai, Fernando Vargas, Mohamed El Dinali, Jessica R. L. Warsch, Roy M. Elias, Young Kwang Chae, Dae Won Kim et al. · 2017 · Clinical Lung Cancer
New tools to prevent cancer growth and spread: a ‘Clever’ approach
Maija Hollmén, Carlos R. Figueiredo, Sirpa Jalkanen · 2020 · British Journal of Cancer
Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome
Alvin Shi, Gyulnara G. Kasumova, William A. Michaud, Jessica Cintolo-Gonzalez, Marta Díaz‐Martínez, Jacqueline F. Ohmura, Arnav Mehta, Isabel Chien, Dennie Tompers Frederick, Sonia Cohen et al. · 2020 · Science Advances
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
Zaoqu Liu, Libo Wang, Long Liu, Taoyuan Lu, Dechao Jiao, Yuling Sun, Xinwei Han · 2021 · Frontiers in Oncology
B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy
Yu Chen Zhao, Yuejiao Cao, Yiqi Chen, Lei Wu, Hua Hang, Chenxia Jiang, Xiaorong Zhou · 2021 · Immunology
Molecular predictors of response to pembrolizumab in thymic carcinoma
Yongfeng He, Archana Ramesh, Yuriy Gusev, Krithika Bhuvaneshwar, Giuseppe Giaccone · 2021 · Cell Reports Medicine
Pan‐cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators
Changwu Wu, Jun Tan, Xiangyu Wang, Chaoying Qin, Wenyong Long, Yimin Pan, Yuzhe Li, Qing Liu · 2022 · iMeta
Rewiring chaperone-mediated autophagy in cancer by a prion-like chemical inducer of proximity to counteract adaptive immune resistance
Jin Yan, Dan Liu, Jingmei Wang, Weiming You, Wenguang Yang, Siqi Yan, Wangxiao He · 2023 · Drug Resistance Updates
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, Irina Sarró, Daniel Öhlund · 2024 · Biochemical Pharmacology
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Saud Almawash · 2025 · Cancers
Molecular dissection of CD8+ T cell dysfunction
Chao Wang, Meromit Singer, A. Anderson · 2017 · Trends in immunology
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
Tsuyoshi Hamada, Thing Rinda Soong, Yohei Masugi, Keisuke Kosumi, Jonathan Andrew Nowak, Annacarolina da Silva, Xinmeng Jasmine Mu, Tyler S. Twombly, Hideo Koh, Juhong Yang et al. · 2018 · OncoImmunology
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma
Bradley D. Shields, Brian S. Koss, Erin M. Taylor, Aaron J. Storey, Kirk L. West, Stephanie D. Byrum, Samuel G. Mackintosh, Rick Edmondson, Fade Aziz Mahmoud, Sara C. Shalin et al. · 2019 · Cancer Research
Genomics and the Immune Landscape of Osteosarcoma
Wu, Chia-Chin, Livingston, J. Andrew · 2020 · Advances in Experimental Medicine and Biology
Emerging biomarkers for cancer immunotherapy in melanoma
Margaret L. Axelrod, Douglas Buckner Johnson, Justin Micah Balko · 2017 · Seminars in Cancer Biology
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer
Louise A. Koopman, Mikkel G. Terp, Gijs G. Zom, Maarten L. Janmaat, Kirstine Jacobsen, Elke Gresnigt-Van den Heuvel, Marcel Brandhorst, Ulf Forssmann, Freddy De Bree, Nora Pencheva et al. · 2019 · JCI Insight
Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment
Tina Krieger, Isobel V. Pearson, Judith A. Bell, Jim P. Doherty, Paul B. Robbins · 2020 · Diagnostic Pathology
Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment
Zhou Jiang, Jennifer L. Hsu, Yintao Li, Gabriel N. Hortobágyi, Mien‐Chie Hung · 2020 · Frontiers in Oncology
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
Yong Wen Qin, Kathryn Blount Bollin, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Kevin B. Kim, Jason Roszik, Khalida Wani, Alexandre Reuben, Sujan Teegala Reddy, Michelle D. Williams et al. · 2020 · Journal for ImmunoTherapy of Cancer
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
Meghana S. Pagadala, Timothy J. Sears, Victoria H. Wu, Eva Pérez‐Guijarro, Hyo Kim, Andrea Castro, James V. Talwar, Cristian González-Colín, Steven Cao, Benjamin Joachim Schmiedel et al. · 2023 · Nature Communications
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, Wenhua Liang, Lu Xie, Ning Li, Yuan Fang, Yiting Wang, Jiayang Liu, Hao Chi et al. · 2024 · Cell
Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies
Peng Jiang, Winston Lee, Xujuan Li, Carl Johnson, Jun S. Liu, Myles A Brown, Jon Christopher Aster, X. Shirley Liu · 2018 · Cell Systems
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade
Rita Greco, Hongjing Qu, Hui Qu, Joachim Theilhaber, Gary Shapiro, Richard C. Gregory, Christopher G. Winter, Natalia V. Malkova, Frank F. Sun, Julie A. Jaworski et al. · 2020 · OncoImmunology
DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Juan Ruiz Bañobre, Ajay Goel · 2018 · Gastroenterology
Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors
Sailing Shi, Shengqing Stan Gu, Tong Han, Wubing Zhang, Lei Huang, Ziyi Li, Deng Pan, Jingxin Fu, Jun Ge, Myles A Brown et al. · 2020 · Clinical Cancer Research
Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy
Zhenwei Su, Zecong Xiao, Jinsheng Huang, Yong Wang, Yongcheng An, Hong Ping Xiao, Yuan Peng, Pengfei Pang, Shisong Han, Kangshun Zhu et al. · 2021 · ACS Applied Materials & Interfaces
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Yang-Hong Dai, Ying-Fu Wang, Po‐Chien Shen, Cheng‐Hsiang Lo, Jen-Fu Yang, Chun‐Shu Lin, Hsing‐Lung Chao, Wen‐Yen Huang · 2021 · npj Genomic Medicine
Immunotherapy in Breast Cancer: When, How, and What Challenges?
Beatriz Henriques, Fernando Mendes, Diana F. Martins · 2021 · Biomedicines
Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells
Jenny Sprooten, Isaure Vanmeerbeek, Angeliki Datsi, Jannes Govaerts, Stefan Naulaerts, Raquel Salvador Laureano, Daniel Borràs, Anna Calvet, Vanshika Malviya, Marc Kuballa et al. · 2024 · Cell Reports Medicine
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Paulina Tomecka, Dominika Kunachowicz, Julia Górczyńska, Michał Gebuza, Jacek Kuźnicki, Katarzyna Skinderowicz, Anna Choromańska · 2024 · International Journal of Molecular Sciences
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies
Shivshankari Rajkumar, Ian R. Watson · 2016 · British Journal of Cancer
Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
Xinyu Yan, Shouyue Zhang, Yun Deng, Peiqi Wang, Qianqian Hou, Heng Xu · 2018 · Frontiers in Pharmacology
Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications
Daniela Massi, Daniela Mihic‐Probst, Dirk Schadendorf, Reinhard Dummer, Mario Mandalà · 2020 · Cancer Treatment Reviews
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms
Charles W. Abbott, Sean M. Boyle, Rachel Marty Pyke, Lee McDaniel, Éric Levy, Fábio C. P. Navarro, Dattatreya Mellacheruvu, Simo V. Zhang, Mengyao Tan, Rose Santiago et al. · 2021 · Clinical Cancer Research
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?
Giuseppe Palmieri, Maria Colombino, Antonio Cossu, Antonio Marchetti, Gerardo Botti, Paolo A. Ascierto · 2017 · Journal of Translational Medicine
Transcriptional Spatial Profiling of Cancer Tissues in the Era of Immunotherapy: The Potential and Promise
Sanjna Nilesh Nerurkar, Denise L M Goh, Chun Chau Lawrence Cheung, Pei Qi Yvonne Nga, Jeffrey Chun Tatt Lim, Joe Poh-Sheng Yeong · 2020 · Cancers
DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer
Meng Qi, Yun‐Xin Lu, Dan‐Yun Ruan, Kai Yu, Yan‐Xing Chen, Min Xiao, Yun Wang, Zexian Liu, Rui‐Hua Xu, Huai‐Qiang Ju et al. · 2021 · Molecular Therapy — Nucleic Acids
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma
Sixue Liu, Hannah M. Knochelmann, Shirley H. Lomeli, Aayoung Hong, Mary S. Richardson, Zhentao Yang, Raymond J. Lim, Yan Wang, Camelia Dumitras, Kostyantyn Krysan et al. · 2021 · Cell Reports Medicine
Pan-Cancer Analysis Reveals a Distinct Neutrophil Extracellular Trap-Associated Regulatory Pattern
Xiaotian Shen, Sun‐Zhe Xie, Jing Xu, Luyu Yang, Lun–Xiu Qin · 2022 · Frontiers in Immunology
Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors
Joseph S. Toker, Julian Bryan Iorgulescu, Alexander Lee Ling, Genaro R. Villa, Josephina A.M.A. Gadet, Laxmi Parida, Gad A. Getz, Catherine J. Wu, David A. Reardon, Ennio Antonio Chiocca et al. · 2023 · Clinical Cancer Research
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
Alessandro Ottaiano, Monica Ianniello, Mariachiara Santorsola, Raffaella Ruggiero, Roberto Sirica, Francesco Sabbatino, Francesco Perri, Marco Cascella, Massimiliano Di Marzo, Massimiliano Berretta et al. · 2023 · Biology
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma
Hyun‐Sung Lee, Hee-Jin Jang, Jong Min Choi, Jun Zhang, Veronica Lenge De Rosen, Thomas M. Wheeler, Ju‐Seog Lee, Thuydung Tu, Peter Jindra, Ronald H. Kerman et al. · 2018 · JCI Insight
The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma
Sun-Hee Kim, Jason Roszik, Sung-Nam Cho, Dai Ogata, Denái R. Milton, Weiyi Peng, David G. Menter, Sühendan Ekmekçioglu, Elizabeth Ann Grimm · 2018 · Clinical Cancer Research
Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ)
Scott J. Callahan, Stephanie Tepan, Yan M Zhang, Helen A. Lindsay, Alexa Burger, Nathaniel R. Campbell, Isabella S. Kim, Travis J. Hollmann, Lorenz Studer, Christian Mosimann et al. · 2018 · Disease Models & Mechanisms
Characterization and Comparison of GITR Expression in Solid Tumors
Luis M. Vence, Samantha L. Bucktrout, Irina Fernandez Curbelo, Jorge M. Blando, Bevin M. Smith, Ashley E. Mahne, John Chia-Yang Lin, Terrence Park, Edward Pascua, Tao Sai et al. · 2019 · Clinical Cancer Research
Choosing tumor mutational burden wisely for immunotherapy: A hard road to explore
Rui Li, Dongsheng Han, Jiping Shi, Yanxi Han, Ping Tan, Rui Zhang, Jinming Li · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Marc Oliva, Douglas Brian Chepeha, Daniel Vilarim Araújo, J. Javier Díaz-Mejía, Peter Olson, Amy Prawira, Anna Spreafico, Scott Victor Bratman, Tina L. T. Shek, John R. de Almeida et al. · 2021 · Journal for ImmunoTherapy of Cancer
MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Yang, Bin, Li, Xi, Fu, Yu, Guo, Ensong, Ye, Youqiong, Li, Fuxia, Liu, Si, Xiao, Rourou, Liu, Chen, Lu, Funian et al. · 2021 · Cancer Research
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma
Weimei Huang, Anqi Lin, Peng Luo, Yuchen Liu, Wentao Xu, Weiliang Zhu, Ting Wei, Qingwen Lyu, Linlang Guo, Jian Zhang · 2020 · Cancer Gene Therapy
A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
Junyu Long, Dongxu Wang, Anqiang Wang, Peipei Chen, Yu Syuan Lin, Jin‐Song Bian, Xu Yang, Mingjun Zheng, Haohai Zhang, Yongchang Zheng et al. · 2022 · Genome Medicine
Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance
Minglei Yang, Cheng-Hao Lin, Yanni Wang, Kang Chen, Haiyue Zhang, Weizhong Li · 2022 · Genome Medicine
Breaking NGF–TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection
Tao Yin, Guoping Wang, Liuyang Wang, Poorva Mudgal, Ergang Wang, Christopher C. Pan, Peter B. Alexander, Haiyang Wu, Chengjie Cao, Yaosi Liang et al. · 2024 · Nature Immunology
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities
Huiyu Wang, Xiaomin Niu, Zhenning Jin, Shaoxing Zhang, Rong Fan, Hua Xiao, Song Hu · 2025 · Journal of Experimental & Clinical Cancer Research
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
Zhen Zhang, Hao‐Xiang Wu, Wu‐Hao Lin, Zixian Wang, Lu-Ping Yang, Zhao-Lei Zeng, Hui Luo · 2021 · BMC Medicine
CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response
Zhongyang Liu, Jiale Liu, Xinyue Liu, Xun Wang, Qiaosheng Xie, Xinlei Zhang, Xiangya Kong, Mengqi He, Yuting Yang, Xinru Deng et al. · 2021 · Nucleic Acids Research
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer
Chang Gon Kim, Gamin Kim, Kyung Hwan Kim, Seyeon Park, Sunhye Shin, Dahee Yeo, Hyo Sup Shim, Hong In Yoon, Sung Yong Park, Sang‐Jun Ha et al. · 2021 · Journal for ImmunoTherapy of Cancer
Tumor-Infiltrating Lymphocytes and Their Role in Solid Tumor Progression
Theresa L. Whiteside · 2022 · Experientia supplementum
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
Biagio Barone, Armando Calogero, Luca Scafuri, Matteo Ferro, Giuseppe Tiziano Lucarelli, Erika Di Zazzo, Enrico Sicignano, Alfonso Falcone, Lorenzo Romano, Luigi De Luca et al. · 2022 · Cancers
Widespread hypertranscription in aggressive human cancers
Matthew Zatzman, Fabio Fuligni, Ryan Ripsman, Tannu Suwal, Federico Comitani, Lisa-Monique Edward, Robert Edward Denroche, Gun Ho Jang, Faiyaz Notta, Steve Gallinger et al. · 2022 · Science Advances
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance
Serena Diazzi, Sophie Tartare‐Deckert, Marcel Deckert · 2023 · Oncogenesis
WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses
Keywan Mortezaee · 2024 · Clinical and Experimental Medicine
Effects of the Community-Based Wellspring Cancer Exercise Program on Functional and Psychosocial Outcomes in Cancer Survivors
Daniel Santa Mina, Darren Au, Jennifer Brunet, Jennifer Michelle Jones, GEORGE A. TOMLINSON, Nathan Taback, D. Field, Antonia Berlingeri, H. Bradley, Doris Howell · 2017 · Current Oncology
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma
Norimitsu Kasahara, Kyoichi Kaira, Pinjie Bao, Tetsuya Higuchi, Yukiko Arisaka, Bilguun Erkhem‐Ochir, Noriaki Sunaga, Yoichi Ohtaki, Toshiki Yajima, Takayuki Kosaka et al. · 2018 · Lung Cancer
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer
Chang Han, Ariella Sasson, Sujaya Srinivasan, Ryan Golhar, Danielle M. Greenawalt, William J. Geese, George Alexander Green, Kim E. Zerba, Stefan A. Kirov, Joseph D. Szustakowski · 2019 · Molecular Diagnosis & Therapy
Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
Dinoop Ravindran Menon, Heinz Hammerlindl, Joachim Torrano, Helmut Schaider, Mayumi Fujita · 2020 · Theranostics
Cell Adhesion Molecules in Plasticity and Metastasis
Jessica A. Smart, Julia E. Oleksak, Edward J. Hartsough · 2020 · Molecular Cancer Research
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S. Grasso, Jennifer Tsoi, Mykola I. Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo, Ameya S. Champhekar, Egmidio Medina, Davis Yuri Torrejon, Daniel Sanghoon Shin et al. · 2020 · Cancer Cell
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
Hildur Helgadóttir, Paola Ghiorzo, Remco van Doorn, Susana Puig, Max Levin, Richard F. Kefford, Martin Lauss, Paola Queirolo, Lorenza Pastorino, Ellen Kapiteijn et al. · 2018 · Journal of Medical Genetics
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies
Chiara Vitale, Monica Marzagalli, Silvia Scaglione, Alessandra Dondero, Cristina Bottino, Roberta Castriconi · 2022 · Cancers
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
Lavinia Anne Spain, Alexander Coulton, Irene Lobón, Andrew Rowan, Désirée Schnidrig, Scott T.C. Shepherd, Benjamin Shum, Fiona Byrne, Maria Goicoechea, Elisa Piperni et al. · 2023 · Cancer Discovery
Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
Dhan Sidhartha Chand, David A. Savitsky, Shanmugarajan Krishnan, Gabriel Mednick, Chloe Delepine, Pilar García‐Broncano, Kah Teong Soh, Wei Wu, Margaret K. Wilkens, Olga O. Udartseva et al. · 2024 · Cancer Discovery
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, Volker Endris, Maximilian Kippenberger, Jonas Leichsenring, Fabian Stögbauer, Josh D. Haimes, Skyler J. Mishkin, Brian A. Kudlow et al. · 2019 · Cancer Immunology Immunotherapy
High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
Ping Mei, C. Eric Freitag, Lai Wei, Yunxiang Zhang, Anil Vasdev Parwani, Zaibo Li · 2020 · Diagnostic Pathology
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors
Michael Lawrence Dougan, Ada Gabriela Blidner, Jennifer Nam Choi, Tim Cooksley, Ilya G. Glezerman, Pamela Ginex, Monica Girotra, Dipti Gupta, Douglas Buckner Johnson, Vickie R. Shannon et al. · 2020 · Supportive Care in Cancer
An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer
Zhijun Zhou, Junxia Zhang, Chao Xu, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Xiuhui Shi, Xiaoping Li, Hanxiang Zhan, Wei Chen et al. · 2021 · EBioMedicine
T‐cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment
Mei‐Chun Cai, Xiaojing Zhao, Min Cao, Pengfei Ma, Minjiang Chen, Jie Wu, Chenqiang Jia, Chunming He, Yujie Fu, Li Tan et al. · 2020 · The Journal of Pathology
AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
Irene Tirado‐González, Arnaud Descot, Devona Soetopo, Aleksandra Nevmerzhitskaya, Alexander Schäffer, Ivan-Maximilano Kur, Ewelina Członka, Carolin Wachtel, Ioanna Tsoukala, Luise Müller et al. · 2021 · Cancer Discovery
AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
Almira Auyez, Emre Sayan, Marina V. Kriajevska, Eugene M. Tulchinsky · 2021 · Cancers
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
Christopher A Alvarez-Breckenridge, Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland, Albert Eusik Kim, Magali A. de Sauvage, Ashish Dahal, Juliana M. Larson et al. · 2022 · Cancer Immunology Research
A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses
Jia Li, Hao Qiao, Fei Wu, Shiyu Sun, Cong Feng, Chaofan Li, Wanjun Yan, Wei Lv, Huizi Wu, Mengjie Liu et al. · 2022 · Frontiers in Immunology
Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy
Valsamo Anagnostou, Blair V. Landon, Jamie E. Medina, Patrick M. Forde, Victor E. Velculescu · 2022 · Science Translational Medicine
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective
David Danielpour · 2024 · Pharmaceuticals
Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
Bicheng Ye, Aimin Jiang, Liang Feng, Changcheng Wang, Xiaoqing Liang, Pengpeng Zhang · 2024 · BioFactors